Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis
Clinical trial update reporting the completion of a study on predicting multidrug-resistant bacterial infections in patients with liver cirr…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
ClinicalTrials.gov entry for a case-control study comparing the Glycotest HCC Panel to AFP for early detection of hepatocellular carcinoma; …
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis
A completed clinical trial evaluating the FibroTouch non-invasive device for assessing liver fibrosis and cirrhosis has posted results. The …
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) [NA]
A completed clinical trial evaluated the efficacy of albumin dialysis using the MARS system to treat hepatic encephalopathy in patients with…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: The Treatment of Hepatocirrhosis and Portal Hypertension [NA]
This clinical trial update reports a completed study on treatments for liver cirrhosis and portal hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients
The completed study from Tanta University analyzed serum zinc and magnesium levels in patients with chronic liver disease and cirrhosis.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study evaluating tipranavir/ritonavir, ribavirin, and pegylated interferon in subjects with mild hepatic impairment …
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Posterior Wall Sparing of Laparoscopic Cholecystectomy in Cirrhotic Patients
This clinical trial evaluates posterior wall-sparing laparoscopic cholecystectomy in patients with cirrhosis and cholecystitis. The study st…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Study of Oxidized Albumin in Liver Transplant Patients
A clinical trial evaluating oxidized albumin in liver transplant patients; the study is currently NOT_YET_RECRUITING in Region Stockholm.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis [Phase 1]
Phase 1 clinical trial of ALE.F02 in adults with advanced liver fibrosis or mild cirrhosis has completed, with an update on its results.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia. [Phase 1]
This clinical trial update reports safety and tolerability findings from a Phase 1 study of OP-724 in patients with liver cirrhosis (includi…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children [EARLY_Phase 1]
This early-phase trial compared three hemostatic agents—chitosan, Ankaferd, and tranexamic acid—for dental extractions in children with live…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating the safety and effectiveness of PRI-724 in patients with cirrhosis due to Hepatitis C or Hepat…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels [Phase 4]
A Phase 4 clinical trial is evaluating the effectiveness of antiviral treatment in patients with chronic hepatitis B–related cirrhosis who h…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes [Phase 4]
A Phase 4 trial of rifaximin in liver cirrhosis investigating endotoxin and haemostatic indexes was terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Monocytic Expression of HLA-DR After Liver Transplantation
This clinical trial update investigates monocytic HLA-DR expression after liver transplantation and the study is listed as completed.
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia [Phase 2]
Phase 2 trial evaluating autologous bone marrow mononuclear cells for children with biliary atresia–related liver cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia [Phase 1, Phase 2]
The update reports the pharmacokinetic profile and preliminary efficacy signals of the investigational drug TNP-2092 in patients with liver …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: 4beta-hydroxycholesterol in Cirrhosis
A University of Oulu trial evaluating 4beta-hydroxycholesterol in liver cirrhosis has been suspended.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Proton Pump Inhibitors in Cirrhotic Patients
A completed clinical trial evaluating proton pump inhibitors in patients with liver cirrhosis.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Statin Impact on Hepatic Decompensation [Phase 2, Phase 3]
Phase 2/3 trial investigating the impact of statins on hepatic decompensation and quality of life has been completed.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia [Phase 2]
Phase 2 trial assessing oral LPCN 1148 for efficacy, safety, and tolerability in male subjects with liver cirrhosis and sarcopenia has compl…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Rifamycin in Minimal Hepatic Encephalopathy [Phase 2]
Phase 2 trial update for rifamycin in minimal hepatic encephalopathy has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection [Phase 3]
Phase 3 clinical trial investigating opioid-sparing anesthesia in patients with liver cirrhosis undergoing liver resection has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA). [Phase 2]
Phase 2 trial update for prolonged-release pirfenidone in advanced residual liver fibrosis due to liver cirrhosis and chronic hepatitis C.